Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases

Cancer Research

Volumn 59, Issue 1, 1999, Pages 241-248

  Putz, Elmar ^a   Witter, Klaus ^a   Offner, Sonja ^a   Stosiek, Peter ^b   Zippelius, Alfred ^a   Johnson, Judith ^a   Zahn, Robert ^c   Riethmüller, Gert ^a   Pantel, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute of Pathology   (Germany)

^c Laboratory of Immunogenetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER CELL CULTURE; CANCER GENETICS; DISSEMINATED CANCER; EPITHELIUM TUMOR; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE MARROW NEOPLASMS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032953810     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Nicolson, G. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res., 47: 1473-1487, 1987.
2. Fidler, I. J., and Radinsky, R. Genetic control of cancer metastasis. J. Natl. Cancer Inst. (Bethesda), 82: 166-168, 1990.
3. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
4. Lindemann, F., Schlimok, G., Dirschedl, P., Witte, J., and Riethmüller, G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet, 3-40: 685-689, 1992.
5. Jauch, K. W., Heiss, M. M., and Cruekner, U. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J. Clin. Oncol., 14: 1810-1817, 1996.
6. Thorban, S., Roder, J. D., Nekarda, H., Funk, A., Siewert, J. R., and Pantel, K. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. J. Natl. Cancer Inst. (Bethesda), 88: 1222-1227, 1996.
7. Pantel, K., Izbicki, J., Passlick, B., Angstwurm, M., Häussinger, K., Thetter, O., and Riethmüller, G. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet, 347: 649-653, 1996.
8. Mansi, J. L., Easton, D., Berger, U., Gazet, J. C., Ford, H. T., Dearnaley, D., and Coombes, R. C. Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur. J. Cancer, 27: 1552-1555, 1991.
9. Cote, R. J., Rosen, P. P., Lesser, M. L., Old, L. J., and Osborne, M. P. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol., 9: 1749-1756, 1991.
10. Harbeck, N., Untch, M., Pache, L., and Eiermann, W. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br. J. Cancer. 69: 566-571, 1994.
11. Diel, I. J., Kaufmann, M., Costa, S. D., Holle, R., von Minckwitz, G., Solomayer, E. F., Kaul, S., and Bastert, G. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J. Natl. Cancer Inst. (Bethesda), 88: 1652-1664, 1996.
12. Schlimok, G., Funke, I., Pantel, K., Strobel, F., Lindemann, F., Witte, J., and Riethmüller, G. Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur. J. Cancer, 27: 1461-1465, 1991.
13. Heiss, M. M., Allgayer, H., Gruetzner, K. U., Funke, I., Babic, R., Jauch, K-W., and Schildberg, F. W. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat. Med., 1: 1035-1039, 1995.
14. Cote, R. J., Beattie, E. J., Chaiwun, B., Shi, S. R., Harvey, J., Chen, S-C., Sherrod, A. E., Groshen, S., and Taylor, C. R. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann. Surg., 222: 415-425, 1995.
15. Brugger, W., Bross, K. J., Glatt, M., Weber, F., Mertelsmann, R., and Kanz, L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood, 83: 636-640, 1994.
16. Shpall, E. J., and Jones, R. B. Release of tumor cells from bone marrow. Blood, 83: 623-625, 1994.
17. Pantel, K., Schlimok, G., Braun, S., Kutler, D., Schaller, G., Funke, I., Izbicki, J., and Riethmüller, G. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. Natl. Cancer Inst. (Bethesda), 85: 1419-1424, 1993.
18. Pantel, K., Schlimok, G., Kutter, D., Schaller, G., Genz, T., Wiebecke, B., Backmann, R., Funke, I., and Riethmüller, G. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res., 51: 4712-4715, 1991.
19. Pantel, K., Izbicki, J. R., Angstwurm, M., Braun, S., Passlick, B., Karg, O., Thetter, O., and Riethmüller, G. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res., 53: 1027-1031, 1993.
20. Pantel, K., Dickmanns, A., Zippelius, A., Klein, C., Shi, J., Hoechtlen-Vollmar, W., Schlimok, G., Weckermann, D., Oberneder, R., Fanning, E., and Riethmüller, G. Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J. Natl. Cancer Inst. (Bethesda), 87: 1162-1168, 1995.
21. Pantel, K., Schlimok, G., Angstwurm, M., Weckermann, C., Schmaus, W., Gath, H., Passlick, B., Izbicki, J., and Riethmüller, G. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother., 3: 165-173, 1994.
22. Stigbrand, T., Andrés, C., Bellanger, L., Bishr Omry, M., Bodenmüller, H., and Bonfrer, H. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 workshop. Tumor Biol., 19: 125-152, 1998.
23. Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A. F., Stein, H., and Mason, D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP-complexes). J Histochem. Cytochem., 32: 219-229, 1984.
24. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. S., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
25. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics., 40: 360-369, 1994.
26. Miller, S. A., Dykes, D. D., and Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16: 1215, 1988.
27. Nevinny-Stickel, C., Hinzpeter, M., Andreas, A., and Albert, E. D. Non-radioactive oligotyping for HLA-DR1-DRw10 using polymerase chain reaction, digoxigenin-labelled oligonucleotides and chemiluminescence detection. Eur. J. Immunogenet., 18: 323-332, 1991.
28. Lehr, J. E., and Pienta, K. J. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J. Natl. Cancer Inst. (Bethesda), 90: 118-123, 1998.
29. Slamon, J. D., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M. F. Studies of the HER-2/neu proto-oncogene in human breast cancer and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
30. Berger, M. S., Locher, G. W., Saurer, S., Gullick, W. J., Waterfield, M. D., Groner, B., and Hynes, N. E. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res., 48: 1238-1243, 1988.
31. Varley, J. M., Swallow, J. E., Brammar, W. J., Whittaker, J. L., and Walker, R. A. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene, 1: 423-430, 1987.
32. D'Emilia, J., Bulowas, K., D'Ercole, K., Wolf, B., Steele, G., Jr., and Summerhayes, I. C. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. Oncogene, 4: 1233-1239, 1989.
33. Volm, M., Efferth, T., and Mattern, J. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res., 12: 11-20, 1992.
34. erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J. Natl. Cancer Inst. (Bethesda), 86: 1140-1145, 1994.
35. Bostwick, D. G. c-erhB-2 oncogene expression in prostatic intraepithelial neoplasia: mounting evidence for a precursor role. J. Natl. Cancer Inst. (Bethesda), 86: 1108-1110, 1994.
36. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J. G., De Smet. C., Brasseur, F., van der Bruggen, P., Lethé, B., and Lurquin, C. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics, 40: 360-369, 1994.
37. Lucas, S., De Smet, C., Arden, K. C., Viars, C. S., Lethé, B., Lurquin, C., and Boon, T. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res., 58: 743-752, 1998.
38. Dubbink, H. J., Verkaik, N. S., Faber, P. W., Trapman, J., Schröder, F. H., and Romijn, J. C. Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase. Biochem. J., 315: 901-908, 1996.
39. Filshie, R. J. A., Zannettino, A. C. W., Makrynikola, V., Gronthos, S., Henniker, A. J., Bendall, L. I., Gottlieb, D. I., Simmons, P. I., and Bradstock, K. F. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies. Leukemia (Baltimore), 12: 414-421, 1998.
40. Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
41. Ardini, E., Tagliabue, E., Magnifico, A., Buto, S., Castronovo, V., Colnaghi, M. I., and Menard, S. Co-regulation and physical association of the 67-kDa monomeric laminin receptor and the α6β4 integrin. J. Biol. Chem., 272: 2342-2345, 1997.
42. Delsite, R., and Djakiew, D. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell line. J. Androl., 17: 481-490, 1996.
43. Bright, R. K., Vocke, C. D., Emmert-Buck, M. R., Duray, P. H., Solomon, D., Fetsch, P., Rhim, J. S., Linehan, W. M., and Topalian, S. L. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res., 57: 995-1002, 1997.
44. Franzen, B., Lindner, S., Alaiya, A. A., Erikson, E., Uruy, K., Hirano, T., Okuzawa, K., and Auer, G. Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins. Br. J. Cancer., 74: 1632-1638, 1996.
45. Schaller, G., Fuchs, I., Pritze, W., Ebert, A., Herbst, H., Pantel, K., Weitzel, H., and Lengyel, E. Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer. Clin. Cancer Res., 2: 1879-1885, 1996.
46. Mork, C., van Deurs, B., and Petersen, O. W. Regulation of vimentin expression in cultured human mammary epithelial cells. Differentiation, 43: 146-156, 1990.
47. Valles, A. M., Boyer, B., Badet, J., Tucker, G. C., Barritault, D., and Thiery, J. P. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc. Natl. Acad. Sci. USA, 87: 1124-1128, 1990.
48. Birchmeier, C., Birchmeier, W., and Brand-Saberi, B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat., 156: 217-226, 1996.
49. Hay, E. D. An overview of epithelio-mesenchymal transformation. Acta Anat., 154: 8-20, 1996.
50. Domagala, W., Markiewski, M., Harezga, B., Dokowicz, A., and Osborn, M. Prognostic significance of tumor cell proliferation rate as determined by the MLB-7 antibody in breast carcinoma: its relationship with vimentin and p53 protein. Clin. Cancer Res., 2: 147-154, 1996.
51. Hülsken, J., Behrens, J., and Birchmeier, W. Tumor-suppressor gene products in cell contacts: the cadherin-APC-armadillo connection. Curr. Opin. Cell Biol., 6: 711-716, 1994.
52. Pantel, K., Dickmanns, A., Zippelius, A., Klein, C., Hoechtlen-Vollmar, W., Schlimok, G., Weckermann, D., Oberneder, R., Shi, J., Fanning, E., and Riethmüller, G. Establishment of carcinoma cell lines from bone marrow of patients with minimal residual cancer: a novel source of tumor cell vaccines. J. Natl. Cancer Inst. (Bethesda), 87: 1160-1168, 1995.
53. Damjanovich, L., Albelda, S. M., Mette, S. A., and Buck, C. A. Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am. J. Respir. Cell Mol. Biol., 6: 197-206, 1992.
54. Korhonen, M., Laitinen, L., Ylänne, J., Koukoulis, G. K., Quaranta, V., Juusela, H., Gould, V. E., and Virtanen, I. Integrin distributions in renal cell carcinomas of various grades of malignancy. Am. J. Pathol., 141: 1161-1171, 1992.
55. Witkowski, C. M., Rabinovitz, I., Nagle, R. B., Affinio, K-S., and Cress, A. E. Characterization of integrin subunits, cellular adhesion and tumorigenicity of four human prostate cell lines. J. Cancer Res. Clin. Oncol., 119: 637-644, 1993.
56. Koretz, K., Brüderlein, S., Henne, C., Fietz, T., Laque, M., and Möller, P. Comparative evaluation of integrin a- and b-chain expression in colorectal carcinoma cell lines and in their tumours of origin. Virchows Arch., 425: 1229-1236, 1994.
57. Gong, J., Wang, D., Sun, L., Zborowska, E., Willson, J. K., and Brattain, M. G. Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells. Cell Growth Differ., 8: 83-90, 1997.
58. O'Brien, V., Frisch, S. M., and Juliano, R. L. Expression of the integrin alpha 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation. Exp. Cell Res., 224: 208-213, 1996.
59. Van der Velde-Zimmermann, D., Verdaasdonk, M. A., Rademakers, L. H., De Weger, R. A., Van den Tweel, J. G., and Jogling, P. Fibronectin distribution in human bone marrow stroma: matrix assembly and tumor cell adhesion via α5β1 integrin. Exp. Cell Res., 230: 111-120, 1997.
60. Boudreau, N., Sympson, C. J., Werb, Z., and Bissell, M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (Washington DC), 267: 891-893, 1995.
61. Albelda, S. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest., 68: 4-17, 1993.
62. Grano, M., Zigrino, P., Colucci, S., Zambonin, G., Trusolino, L., Serra, M., Baldini, N., Teti, A., Marchisio, P. C., and Zallone, A. Z. Adhesion properties and integrin expression of cultured human osteoclast-like cells. Exp. Cell Res., 212: 209-218, 1994.
63. Liapis, H., Flath, A., and Kitazawa, S. Integrin αVβ3 expression by bone-residing breast cancer metastases. Diagn. Mol. Pathol., 5: 127-135, 1996.
64. Martignone, S., Menard, S., Bufalino, R., Cascinelli, N., Pellegrini, R., Tagliabue, E., Andreola, S., Rilke, F., and Colnaghi, M. I. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J. Natl. Cancer Inst. (Bethesda), 85: 398-402, 1993.
65. Pellegrini, R., Martignone, S., Ménard, S., and Colnaghi, M. I. Laminin receptor expression and function in small-cell lung carcinoma. Int. J. Cancer 8 (Suppl.): 116-120, 1994.
66. Tuszynski, G. P., Wang, T. N., and Berger, D. Adhesive proteins and the hemalogenous spread of cancer. Acta Haematol., 97: 29-39, 1997.
67. Johnson, J. P., Stade, B. G., Holzmann, B., Schwäble, W., and Riethmüller, G. De novo expression of intercellular-adhesion molecule I in melanoma correlates with increased risk of metastasis. Proc. Natl. Acad. Sci. USA. 86: 641-644, 1989.
68. Sers, C., Riethmüller, G., and Johnson, J. P. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread. Cancer Res., 54: 5689-5694, 1994.
69. Lehmann, J. M., Holzmann, B., Breitbart, E. W., Scnmiegelow, P. M., Riethmüller, G., and Johnson, J. P. Discrimination between benign and malignant cells of melanocylic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res., 47: 841-845, 1987.
70. Xie, S., Luca, M., Huang, S., Gutman, M., Reich, R., Johnson, J. P., and Bar-Eli, M. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res., 57: 2295-2303, 1997.
71. Günthert, U. CD44 in malignant disorders. Curr. Top. Microbiol. Immunol., 213: 271-285, 1996.
72. Noordzij, M. A., van Steenbrugge, G-J., Verkaik, N. S., Schröder, F. H., and van der Kwast, T. H. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin. Cancer Res., 3: 805-815, 1997.
73. Soukka, K. T. Salmi, M., Joensuu, H., Häkkinen, L., Sointu, P., Koulu, L., Kalimo, K., Klemi, P., Grénman, R., and Jalkanen, S. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res., 57: 2281-2289, 1997.
74. Kogerman, P., Sy, M-S., and Culp, L. A. Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: facilitated retention in the lung vasculature. Proc. Natl. Acad. Sci. USA, 94: 13233-13238, 1997.
75. Pantel, K., Braun, S., Passlick, B., and Schlimok, G. Minimal residual epithelial cancer: diagnostic approaches and prognostic relevance. Prog. Histochem. Cytochem., 30: 1-60, 1996.